Listed

CF Bankshares Inc.: Form 10-Q for the period ended Mar 31, 2024

Filed with the SEC on May 14, 2024 and accepted by EDGAR at May 14, 2024, 14:16 ET.

Share

Management's discussion and analysis

As filed, 1,599 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) None.

(b) Not applicable.

(c) The following table provides information concerning purchases of the Holding Company’s shares of common stock made by or on behalf of the Company or any “affiliated purchaser” as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended, during the three months ended March 31, 2024.

Period Total number of common shares purchased Average price paid per common share Total number of common shares purchased as part of publicly announced plans or programs (3) Maximum number of common shares that may yet be purchased under the plans or programs
January 1, 2024 through January 31, 2024 6,247 (1) 20.61 5,050 235,447
February 1, 2024 through February 29, 2024 5,265 (2) 21.28 800 234,647
March 1, 2024 through March 31, 2024 3,000 20.03 3,000 231,647
Total 14,512 $20.73 8,850

(1) Includes 1,197 shares of common stock surrendered to the Company for the payment of taxes upon the vesting of restricted stock and 5,050 shares of common stock repurchased under the stock repurchase program.

(2) Includes 4,465 shares of common stock surrendered to the Company for the payment of taxes upon the vesting of restricted stock and 800 shares of common stock repurchased under the stock repurchase program.

(3) On July 5, 2023, the Company’s Board of Directors authorized a new stock repurchase program pursuant to which the Company may repurchase up to 250,000 shares of the Company’s common stock on or before June 30, 2024.

Risk factors

As filed, 459 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There are certain risks and uncertainties in our business that could cause our actual results to differ materially from those anticipated. A detailed discussion of our risk factors is included in “Item 1A. Risk Factors” of Part I of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There were no material changes to those risk factors as presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Interest expense3 months2024-01-01 to 2024-03-31$17.8mus-gaap:InterestExpense
Income tax3 months2024-01-01 to 2024-03-31$695.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-01-01 to 2024-03-31$3.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-01-01 to 2024-03-31$0.47us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-01-01 to 2024-03-31$0.48us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-01-01 to 2024-03-316,478,177 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2024-01-01 to 2024-03-31−$1.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2024-01-01 to 2024-03-31$3.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2024-01-01 to 2024-03-31$386.0kus-gaap:PaymentsOfDividendsCommonStock
Cash and equivalentsAt period end2024-03-31$236.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2024-03-31$2.04bnus-gaap:Assets
Total liabilitiesAt period end2024-03-31$1.88bnus-gaap:Liabilities
Shareholders' equityAt period end2024-03-31$158.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001070680-24-000017. Last ingested by Listed: Nov 13, 2026, 01:50 ET. Listed shows no prices and gives no investment advice.